National Survey on the Lockdown of Children With Disabilities (ECHO)
May 15, 2020 updated by: University Hospital, Brest
Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic: Messages From Families Answering the ECHO French National Survey
During the COVID-19 pandemic, lockdown measures were established in France affecting the life course of children with disabilities.
This study aimed at identifying the experiences, main difficulties and needs of these children and their parents during the lockdown period.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
2500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brest, France, 29609
- CHRU de Brest
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children with motor disabilities, with and without associated impairement
Description
Inclusion Criteria:
-children (age 0-18 years) with motor disabilities (with and without associated impairement), living in France.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Experience during lockdown
Time Frame: From the 6th of April 2020 until the 11th of May 2020
|
Identify the lived experience, the needs, and difficulties of children with motor disabilities and their parents during the COVID-2019 lockdown
|
From the 6th of April 2020 until the 11th of May 2020
|
|
Health risk during lockdown
Time Frame: From the 6th of April 2020 until the 11th of May 2020
|
Identify the risks on health of children with motor disabilities due to the COVID-2019 lockdown
|
From the 6th of April 2020 until the 11th of May 2020
|
|
Impact on medical and rehabilitation follow up
Time Frame: From the 6th of April 2020 until the 11th of May 2020
|
Identify the impact on the medical and rehabilitation follow up of children with disabilities during COVID-19 lockdown
|
From the 6th of April 2020 until the 11th of May 2020
|
|
Impact on daily living
Time Frame: From the 6th of April 2020 until the 11th of May 2020
|
Identify the impact on the daily living of children with motor disabilities and their families during the COVID-19 lockdown
|
From the 6th of April 2020 until the 11th of May 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Experience during lockdown
Time Frame: From the 24th of April 2020 until the 11th of May 2020
|
Identify the lived experience, the needs, and difficulties of children without motor disabilities and their parents during the COVID-2019 lockdown
|
From the 24th of April 2020 until the 11th of May 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 7, 2020
Primary Completion (Actual)
May 11, 2020
Study Completion (Actual)
May 11, 2020
Study Registration Dates
First Submitted
May 15, 2020
First Submitted That Met QC Criteria
May 15, 2020
First Posted (Actual)
May 20, 2020
Study Record Updates
Last Update Posted (Actual)
May 20, 2020
Last Update Submitted That Met QC Criteria
May 15, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHRU de BREST ECHO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.